The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 24, 2017
Filed:
Jan. 12, 2016
Applicant:
Biomarin Pharmaceutical Inc., Novato, CA (US);
Inventors:
James R. Rusche, Framingham, MA (US);
Norton P. Peet, North Andover, MA (US);
Allen Hopper, Katonah, NY (US);
Assignee:
BIOMARIN PHARMACEUTICAL INC., Novato, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/166 (2006.01); C07C 233/80 (2006.01); A61K 31/00 (2006.01); A61K 31/16 (2006.01); C07C 235/16 (2006.01); C07C 237/22 (2006.01); C07C 255/57 (2006.01); C07C 311/16 (2006.01); C07C 311/19 (2006.01); C07C 317/44 (2006.01); C07C 323/62 (2006.01); C07D 209/48 (2006.01); C07D 213/30 (2006.01); C07D 231/56 (2006.01); C07D 277/56 (2006.01); C07D 295/14 (2006.01); C07D 307/84 (2006.01); C07D 409/12 (2006.01); C07D 213/81 (2006.01); C07D 217/24 (2006.01); C07D 231/12 (2006.01); C07D 237/24 (2006.01); C07D 241/24 (2006.01); C07D 241/44 (2006.01); C07D 271/12 (2006.01); C07D 295/15 (2006.01); C07D 307/85 (2006.01); C07D 333/38 (2006.01);
U.S. Cl.
CPC ...
C07C 233/80 (2013.01); A61K 31/00 (2013.01); A61K 31/16 (2013.01); C07C 235/16 (2013.01); C07C 237/22 (2013.01); C07C 255/57 (2013.01); C07C 311/16 (2013.01); C07C 311/19 (2013.01); C07C 317/44 (2013.01); C07C 323/62 (2013.01); C07D 209/48 (2013.01); C07D 213/30 (2013.01); C07D 213/81 (2013.01); C07D 217/24 (2013.01); C07D 231/12 (2013.01); C07D 231/56 (2013.01); C07D 237/24 (2013.01); C07D 241/24 (2013.01); C07D 241/44 (2013.01); C07D 271/12 (2013.01); C07D 277/56 (2013.01); C07D 295/14 (2013.01); C07D 295/15 (2013.01); C07D 307/84 (2013.01); C07D 307/85 (2013.01); C07D 333/38 (2013.01); C07D 409/12 (2013.01); C07C 2601/02 (2017.05); C07C 2601/14 (2017.05);
Abstract
This invention relates to compounds of Formula (I) wherein Cy, L, Y, R, L, and Ar2 are defined herein, for the treatment of cancers, inflammatory disorders, and neurological conditions.